Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elite Health SystemsEHSI 35 3-Year EBITDA Growth Rate is 4.20% as of Jun. 2026. GuruFocus rates EHSI with a GF Score™ of 35/100. The stock has 3 warning signs investors should review. Among 525 Healthcare Providers & Services companies, Elite Health Systems ranks worse than 61.9% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 4.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Elite Health Systems was 103.90% per year. The lowest was -48.90% per year. And the median was -1.60% per year.
Elite Health Systems (OTCPK:EHSI) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Elite Health Systems 3-Year EBITDA Growth Rate Related Terms
EHSI vs CCM, CCEL, GBCS: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Elite Health Systems's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elite Health Systems 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Elite Health Systems's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Elite Health Systems's 3-Year EBITDA Growth Rate falls into.
Elite Health Systems 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 4.20% mean?
Elite Health Systems (EHSI) has a 3-Year EBITDA Growth Rate of 4.20% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Elite Health Systems and its competitors. According to the industry distribution chart, Elite Health Systems ranks #325 out of 525 companies in the Healthcare Providers & Services industry, placing it in the top 61.9%.
Is Elite Health Systems' 3-Year EBITDA Growth Rate too high?
Elite Health Systems' current 3-Year EBITDA Growth Rate is 4.20%. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 9.90. Elite Health Systems' value of 4.20% is 57.6% below this industry median. Based on the distribution chart, Elite Health Systems ranks #325 out of 525 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Elite Health Systems has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Elite Health Systems' 3-Year EBITDA Growth Rate compare to CCM and CCEL?
According to the Healthcare Providers & Services industry distribution chart, Elite Health Systems ranks #325 out of 525 companies for 3-Year EBITDA Growth Rate. This places Elite Health Systems in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 9.90. Elite Health Systems' value of 4.20% is 57.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 9.90, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elite Health Systems's current 3-Year EBITDA Growth Rate of 4.20% is 57.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Elite Health Systems and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 9.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elite Health Systems's current 3-Year EBITDA Growth Rate is 4.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elite Health Systems stock overvalued right now?
Elite Health Systems (EHSI) has a current 3-Year EBITDA Growth Rate of 4.20%. The current 3-Year EBITDA Growth Rate is 4.20% and 57.6% below the Healthcare Providers & Services industry median of 9.90. Elite Health Systems' overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Elite Health Systems (EHSI), the current 3-Year EBITDA Growth Rate is 4.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Elite Health Systems Inc is developing Medicare Advantage plans and offering other healthcare-related services with a focus on improving and providing access to healthcare, principally to senior and special needs groups in selected locations. The Company operates through its wholly owned subsidiaries. The company's operating segment includes ESS, which designs, markets, and manages a Medicare Advantage plan or Medicare Part C - a government-approved health plan that delivers Medicare benefits through a managed care or coordinated care model. PSS provides a comprehensive suite of tailored healthcare management solutions to medical practices that enhance operational efficiency, compliance, and patient care.
35GF Score
Get the complete analysis for EHSI
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EHSI has been successfully added to your 
